Areas of Expertise and Treatments
Chemotherapy uses anti-cancer medicines to destroy or control cancer cells and may be used alone or in combination with surgery, radiation therapy or other systemic treatments.
Immunotherapy helps the immune system recognise and attack cancer cells and may be recommended for selected cancers based on tumour type, stage and biomarker results.
Targeted therapy uses medicines designed to act on specific molecular abnormalities or biological pathways involved in cancer growth and survival.
Hormone therapy is used for selected hormone-sensitive cancers to block or reduce hormonal signals that contribute to tumour growth.
Precision oncology uses tumour biology, molecular testing and genomic information to help personalise treatment strategies for suitable cancer patients.
Medical treatment for breast cancer may involve chemotherapy, targeted therapy, immunotherapy or hormone therapy depending on tumour biology, stage and receptor status.
Systemic treatment for gastrointestinal cancers may include chemotherapy, targeted therapy and other personalised treatments depending on the primary tumour site and molecular characteristics.
Lung cancer treatment may include chemotherapy, targeted therapy and immunotherapy selected according to cancer subtype, stage, driver mutations and biomarker findings.
Medical oncology treatment for head and neck cancers may include chemotherapy, targeted therapy or immunotherapy as part of multidisciplinary cancer care.
Systemic treatment for colorectal cancer may involve chemotherapy and targeted therapies selected according to disease stage and tumour molecular profile.
Medical treatment for prostate cancer may involve hormone-based treatment and other systemic therapies depending on cancer stage, biological behaviour and previous treatment.
Sarcoma treatment may require systemic anti-cancer therapy as part of a multidisciplinary plan based on tumour subtype, stage and location.
Lymphoma treatment may involve chemotherapy, immunotherapy and targeted medicines according to lymphoma subtype, stage and risk profile.
Multiple myeloma treatment may include combination systemic therapy, targeted medicines and other hematology-oncology treatments based on disease characteristics and patient fitness.
Hematological cancer care involves the medical management of blood and lymphatic malignancies using systemic treatments selected according to the specific diagnosis and disease biology.